Aller au contenu principal

Case details

Case Number: ACT_10334/2025

  • Patent number:
    EP4252857 - METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)

  • Proceeding type: Proceeding

  • Action/Application: Infringement Action

  • Defendants:
    Amgen S.R.L. Represented by Johannes Heselberger
    Amgen S.A.S. Represented by Johannes Heselberger
    Amgen NV Represented by Johannes Heselberger
    Amgen GmbH Represented by Johannes Heselberger
    Amgen Inc. Represented by Johannes Heselberger
    Amgen Europe B.V. Represented by Johannes Heselberger
    Amgen B.V. Represented by Johannes Heselberger

  • Claimants:
    Regeneron Pharmaceuticals Inc. Represented by Agathe Michel-de Cazotte
    Sanofi Biotechnology SAS Represented by Agathe Michel-de Cazotte

  • Judges:
    Andras Kupecz
    Berenice Thom
    Ronny Thomas
    Xavier DORLAND-GALLIOT

  • Court Division: First instance, Local division - Düsseldorf

  • Date of Formal receipt: 2025-02-28 00:00:00

  • Language of proceeding: Anglais